{
  "docId": "019dd923-5e88-73ef-bd5a-c8877c2d773b",
  "docSlug": "62a053437732d31d",
  "documentTitle": "250114 FRE prsn JPM SFO 0",
  "authorId": "JPMorgan",
  "authorName": "Fresenius",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "equity_research",
  "sourceTypeLabel": "Equity research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 7,
  "pageCount": 15,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "market_landscape",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 12,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "comparison_table",
    "donut_chart",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5a-c8877c2d773b/7",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5a-c8877c2d773b",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5a-c8877c2d773b.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-c8877c2d773b#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.8,
        "x": 0.13,
        "y": 0.6
      },
      "kind": "chart",
      "text": "Donut charts representing segment share for each business unit",
      "attrs": null,
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e10181d5-51b1-42e3-a73d-8c52c8d563f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Revenue 2023: €3.8B",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-28a9-71be-806d-ad39e344cd31",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.038,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Including Ketoanalogues; Infusion & Nutrition Systems; Source: IQVIA, Fresenius Kabi internal analysis; market data refers to Fresenius Kabi's addressable markets",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a76da888-e074-4ea8-8175-145a18d1fd5e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.92,
        "x": 0.038,
        "y": 0.248
      },
      "kind": "table",
      "text": "Matrix of business segments (Pharma, Nutrition, MedTech, Biopharma) vs metrics (Overview, Key facts, Segment share, Revenue 2023)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c19c5e78-0678-498c-8030-138521741279",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.78,
        "x": 0.038,
        "y": 0.05
      },
      "kind": "title",
      "text": "Fresenius Kabi: Leveraging growth potential in highly relevant fields",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dcfa9e76-cdc4-4d2a-938a-06ce3e4e49b0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "d7816e95-3d87-461e-9cbd-26530c4ef183",
      "evidence": "The slide features a matrix with business segments (Pharma, Nutrition, MedTech, Biopharma) vs metrics, which resembles a 2x2 matrix.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 7,
      "from": 6,
      "beatId": "1a7dc3a3-3256-47cb-8af9-ce2691989000",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Problem & Complication",
      "beatSlug": "consultants-gambit-problem-complication",
      "evidence": "Slides 6-7 highlight the driving forces of tomorrow's healthcare and Fresenius Kabi's positioning.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "0f7b9246-98b4-450f-9b9b-af0a2ddf2192",
      "evidence": "Slides 6-10 emphasize the need for transformation and growth.",
      "position": 0,
      "objective": "Highlighting the importance of transformation",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}